Literature DB >> 2256523

Factors affecting the enterohepatic circulation of oral contraceptive steroids.

M L Orme1, D J Back.   

Abstract

Oral contraceptive steroids may undergo enterohepatic circulation, but it is relevant for only estrogens, because these compounds can be directly conjugated in the liver. Animal studies show convincing evidence of the importance of the enterohepatic circulation, but studies in humans are much less convincing. The importance of the route and the rate of metabolism of ethinyl estradiol are reviewed. Some antibiotics have been reported anecdotally to reduce the efficacy of oral contraceptive steroids, but controlled studies have not confirmed this observation. Although gut flora are altered by oral antibiotics, the blood levels of ethinyl estradiol are not reduced, and one antibiotic at least (cotrimoxazole) enhances the activity of ethinyl estradiol.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2256523     DOI: 10.1016/0002-9378(90)90555-l

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  9 in total

1.  Absence of pharmacokinetic interactions of the combined contraceptive vaginal ring NuvaRing with oral amoxicillin or doxycycline in two randomised trials.

Authors:  Peter Dogterom; Michiel W van den Heuvel; Torben Thomsen
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

Review 2.  Drug interactions with antiretrovirals.

Authors:  Linda M Catanzaro; Judianne C Slish; Robert DiCenzo; Gene D Morse
Journal:  Curr HIV/AIDS Rep       Date:  2004-06       Impact factor: 5.071

Review 3.  Interactions between oral contraceptives and antifungals/antibacterials. Is contraceptive failure the result?

Authors:  E Weisberg
Journal:  Clin Pharmacokinet       Date:  1999-05       Impact factor: 6.447

Review 4.  Gender effects in pharmacokinetics and pharmacodynamics.

Authors:  R Z Harris; L Z Benet; J B Schwartz
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

Review 5.  Oral contraceptives. Are drug interactions of clinical significance?

Authors:  G M Shenfield
Journal:  Drug Saf       Date:  1993-07       Impact factor: 5.606

6.  Ursodeoxycholic acid does not affect ethinylestradiol bioavailability in women taking oral contraceptives.

Authors:  Ornella Baisini; Federica Benini; Felice Petraglia; Wilhelm Kuhnz; Santo Scalia; Hanns-Ulrich Marschall; Gabriele Brunetti; Horst-Dietmar Tauschel; Alberto Lanzini
Journal:  Eur J Clin Pharmacol       Date:  2004-09       Impact factor: 2.953

7.  P-glycoprotein (P-gp/MDR1)-mediated efflux of sex-steroid hormones and modulation of P-gp expression in vitro.

Authors:  Winnie Y Kim; Leslie Z Benet
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

8.  The mind-body-microbial continuum.

Authors:  Antonio Gonzalez; Jesse Stombaugh; Catherine Lozupone; Peter J Turnbaugh; Jeffrey I Gordon; Rob Knight
Journal:  Dialogues Clin Neurosci       Date:  2011       Impact factor: 5.986

9.  Gut microbiota and host Cyp450s co-contribute to pharmacokinetic variability in mice with non-alcoholic steatohepatitis: Effects vary from drug to drug.

Authors:  Jing Guo; Ying Xu; Li-Jie Chen; Song-Xia Zhang; Yu-Ligh Liou; Xiao-Ping Chen; Zhi-Rong Tan; Hong-Hao Zhou; Wei Zhang; Yao Chen
Journal:  J Adv Res       Date:  2021-10-18       Impact factor: 12.822

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.